文献速递急性肾损伤

开发预测心脏手术后急性肾损伤进展的生物标志物组合

Developing Biomarker Panels to Predict Progression of Acute Kidney Injury After Cardiac Surgery.
PubMed 文献 · Kidney Int Rep · 2019-08-30

本研究基于354例心脏手术后发生急性肾损伤的患者,在诊断时检测38种候选生物标志物,采用贝叶斯模型平均和随机森林构建预测AKI进展的模型。贝叶斯模型平均组合3种标志物的乐观校正AUC为0.75(95%CI:0.68,0.82),随机森林经中心特异性变换后AUC为0.80(95%CI:0.72,0.88)。结论认为先进统计技术组合标志物较单一标志物仅 modest 改善。

要点

  • 心脏手术后AKI患者中,组合生物标志物预测进展的AUC为0.75~0.80。
  • 贝叶斯模型平均仅需3种标志物,性能与使用全部标志物的随机森林相当。
  • 生物标志物组合对AKI进展的预测提升有限,临床价值需进一步验证。

核心结论

  • 应用先进统计技术组合生物标志物较单一标志物仅带来适度性能提升。

研究设计与样本

  • 前瞻性队列研究,分析数据集包含354例心脏手术后符合AKI标准的患者。

主要发现

  • 贝叶斯模型平均组合3种生物标志物,乐观校正AUC为0.75(95%CI:0.68,0.82)。
  • 随机森林名义上使用全部标志物,估计AUC为0.74(95%CI:0.66,0.82)。
  • 随机森林经中心特异性变换后,估计AUC为0.80(95%CI:0.72,0.88)。

临床怎么用

  • 生物标志物组合模型可用于识别心脏手术后AKI进展风险较高的患者,但预测性能有限,需结合临床评估。

局限性

  • 生物标志物组合的预测性能仅适度优于单一标志物,临床效用尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Acute kidney injury (AKI) is a frequent complication of cardiac surgery, but only a fraction of cardiac surgery patients that experience postoperative AKI have progression to more severe stages. Biomarkers that can distinguish patients that will experience progression of AKI are potentially useful for clinical care and/or the development of therapies. METHODS: Data come from a prospective cohort study of cardiac surgery patients; the analytic dataset contained data from 354 cardiac surgery patients meeting criteria for AKI following surgery. Candidate predictors were 38 biomarkers of kidney function, insult, or injury measured at the time of AKI diagnosis. The outcome was AKI progression, defined as worsening of AKI Network stage. We investigated combining biomarkers with Bayesian model averaging (BMA) and random forests of classification trees, with and without center transformation. For both approaches, we used resampling-based methods to avoid optimistic bias in our assessment of model performance. RESULTS: BMA yielded a combination of 3 biomarkers and an optimism-corrected estimated area under the receiver operating characteristic curve (AUC) of 0.75 (95% confidence interval [CI]: 0.68, 0.82). The random forests approach, which nominally uses all biomarkers, had an estimated AUC of 0.74 (95% CI: 0.66, 0.82). A second application of random forests applied to biomarker values after a center-specific transformation had an estimated AUC of 0.80 (95% CI: 0.72, 0.88). CONCLUSION: These findings suggest that the application of advanced statistical techniques to combine biomarkers offers only modest improvements over use of single biomarkers alone. This exemplifies a common experience in biomarker research: combinations of modestly performing biomarkers often also have modest performance.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Kerr KF, Morenz ER, Roth J, et al. Developing Biomarker Panels to Predict Progression of Acute Kidney Injury After Cardiac Surgery. Kidney Int Rep. 2019. PMID: 31844804. doi:10.1016/j.ekir.2019.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。